Literature DB >> 8774738

Structural analysis of unsaturated hexasaccharides isolated from shark cartilage chondroitin sulfate D that are substrates for the exolytic action of chondroitin ABC lyase.

K Sugahara1, S Nadanaka, K Takeda, T Kojima.   

Abstract

The enzymatic action of highly purified chondroitin ABC lyase from Proteus vulgaris is dependent on the size of the substrate, and the enzyme does not cleave tetrasaccharides, irrespective of their sulfation profiles [Sugahara, K., Shigeno, K., Masuda, M., Fujii, N., Kurosaka, A. & Takeda, K. (1994) Carbohydr. Res. 255, 145-163]. To characterize the enzyme action in more detail, we isolated nine sulfated hexasaccharides from commercial shark cartilage chondroitin sulfate D, after partial digestion with highly purified chondroitin ABC lyase, by means of gel chromatography and HPLC on an amine-bound silica column. Structural analysis by 500-MHz H-NMR spectroscopy, and enzymatic digestion in conjunction with HPLC, demonstrated that these hexasaccharides, with the common core saccharide structure delta 4 HexA (alpha 1-3)GalNAc(beta 1-4)GlcA(beta 1-3)GalNAc(beta 1-4) GlcA(beta 1-3)GalNAc(where delta 4 HexA and GlcA represent 4-deoxy-alpha-L-threo-hex-4-enepyranosyluronic acid and glucuronic acid, respectively) bear three or four sulfate groups in different combinations. In the hexasaccharides, the D, disaccharide unit GlcA2-SO3 (beta 1-3) GalNAc4SO(3-) which is characteristic of chondroitin sulfate D, was arranged on the reducing side of the A disaccharide unit GlcA(beta 1-3)GalNAc4SO(3)-, and thus formed an A-D tetrasaccharide sequence GlcA(beta 1-3)GalNAc4SO(3)-(beta 1-4)GlcA2SO(3)-(beta 1-3) GalNAc6SO(3)-. Analysis of the degradation products of these hexasaccharides with highly purified chondroitin ABC lyase indicated that the enzyme preferentially acted on the unsaturated hexasaccharides in an exolytic fashion and removed an unsaturated disaccharide unit from the non-reducing termini, irrespective of the sulfation profiles of the hexasaccharides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774738     DOI: 10.1111/j.1432-1033.1996.0871u.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes.

Authors:  Na Lin; Xiaoli Mo; Yang Yang; Hong Zhang
Journal:  Glycoconj J       Date:  2017-01-14       Impact factor: 2.916

2.  Structural determination of novel tetra- and hexasaccharide sequences isolated from chondroitin sulfate H (oversulfated dermatan sulfate) of hagfish notochord.

Authors:  C Ueoka; S Nadanaka; N Seno; K H Khoo; K Sugahara
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

3.  Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas.

Authors:  Gerdy B Ten Dam; Shuhei Yamada; Fumi Kobayashi; Anurag Purushothaman; Els M A van de Westerlo; Johan Bulten; Anders Malmström; Kazuyuki Sugahara; Leon F Massuger; Toin H van Kuppevelt
Journal:  Histochem Cell Biol       Date:  2009-04-10       Impact factor: 4.304

4.  A chondroitin sulfate and hyaluronic acid lyase with poor activity to glucuronyl 4,6-O-disulfated N-acetylgalactosamine (E-type)-containing structures.

Authors:  Chune Peng; Qingbin Wang; Shumin Wang; Wenshuang Wang; Runmiao Jiao; Wenjun Han; Fuchuan Li
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

5.  Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer's Disease β Secretase, BACE1.

Authors:  Courtney J Mycroft-West; Anthony J Devlin; Lynsay C Cooper; Scott E Guimond; Patricia Procter; Marco Guerrini; Gavin J Miller; David G Fernig; Edwin A Yates; Marcelo A Lima; Mark A Skidmore
Journal:  Mar Drugs       Date:  2021-04-03       Impact factor: 5.118

6.  Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities.

Authors:  Fatma Krichen; Hajer Bougatef; Federica Capitani; Ikram Ben Amor; Imed Koubaa; Jalel Gargouri; Francesca Maccari; Veronica Mantovani; Fabio Galeotti; Nicola Volpi; Ali Bougatef
Journal:  RSC Adv       Date:  2018-11-12       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.